Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides.

Authors:
Kenan Aydogan
Kenan Aydogan
Uludag University
Turkey
Hayriye Saricaoglu
Hayriye Saricaoglu
Uludag University Medical Faculty
Turkey
Hakan Turan
Hakan Turan
Duzce University Medical Faculty
Turkey

Photodermatol Photoimmunol Photomed 2008 Jun;24(3):128-33

Department of Dermatology, Faculty of Medicine, Uludag University, Bursa, Turkey.

Background/purpose: Narrowband (NB) UVB (NB-UVB) phototherapy has recently demonstrated high levels of efficacy and tolerability in a variety of skin diseases. The purpose of the present study was to assess the efficacy of NB-UVB phototherapy in the management of pityriasis lichenoides (PL).

Methods: The therapeutic response in 31 PL patients (23 pityriasis lichenoides et varioliformis acuta; PLEVA, eight pityriasis lichenoides chronica; PLC) treated with NB-UVB phototherapy between 2000 and 2007 was assessed.

Results: NB-UVB treatment led to a complete response (CR) in 15 out of 23 PLEVA patients (65.2%) with a mean cumulative dose of 23 J/cm(2) after a mean number of 43.4 exposures and a partial response (PR) in eight patients (34.8%) with a cumulative dose of 15.6 J/cm(2) after a mean number of 32.3 exposures. NB-UVB treatment led to CR in seven out of eight PLC patients (87.5%) with a mean cumulative dose of 18.4 J/cm(2) after a mean number of 45.8 exposures and PR in one patient (12.5%) with a cumulative dose of 9.1 J/cm(2) after a mean number of 19 exposures. Relapses occurred in four PL patients within a mean time period of 6 months.

Conclusion: NB-UVB therapy is an effective, safe and practical alternative treatment modality for the management of PLEVA and PLC.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0781.2008.00350.xDOI Listing
June 2008
13 Reads

Publication Analysis

Top Keywords

pityriasis lichenoides
16
cumulative dose
16
j/cm2 number
16
nb-uvb phototherapy
12
nb-uvb treatment
8
treatment led
8
dose j/cm2
8
response patients
8
narrowband uvb
8
nb-uvb
6
patients
5
2007 assessedresults
4
dose 184
4
184 j/cm2
4
2000 2007
4
311 tl01
4
led complete
4
patients 875%
4
management pleva
4
875% cumulative
4

Similar Publications

Narrowband UVB phototherapy for small plaque parapsoriasis.

J Eur Acad Dermatol Venereol 2006 May;20(5):573-7

Department of Dermatology, Uludag University Faculty of Medicine, Bursa, Turkey.

Background: Narrowband UVB (NB-UVB) phototherapy has been shown to be effective for the treatment of various dermatoses.

Objective: To analyze the effects of NB-UVB phototherapy for small plaque parapsoriasis (SPP).

Methods: The response of 45 patients (24 females, 21 males, age range 20-58 years) with histologically confirmed SPP were assessed. Read More

View Article
May 2006

Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica.

J Am Acad Dermatol 2002 Sep;47(3):410-4

Department of Dermatology, Azienda Spedali Civili di Brescia, Brescia, Italy.

Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases.

Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC).

Methods: Eight patients (3 with PLEVA and 5 with PLC) received 60 J/cm(2) UVA1 daily until remission. Read More

View Article
September 2002

Narrowband ultraviolet-B phototherapy in pityriasis lichenoides chronica.

J Dermatolog Treat 2009 ;20(2):109-13

Department of Dermatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Background: Current knowledge about the efficacy of narrowband UVB therapy for the treatment of pityriasis lichenoides is limited.

Objective: The aim of this study was to investigate the efficacy of narrowband UVB therapy for the treatment of pityriasis lichenoides chronica (PLC).

Methods: Data were retrospectively collected following a review of patient phototherapy and medical charts, and telephone interviews were performed for follow-up information. Read More

View Article
July 2009

Phototherapy for pityriasis lichenoides: our experience.

Cutan Ocul Toxicol 2013 Jun 13;32(2):124-7. Epub 2012 Sep 13.

Hospital de Curry Cabral, Dermatology and Venereology Department, Lisbon, Portugal.

Pityriasis lichenoides is a benign disease that includes a continuous spectrum with two polar ends: pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC). Although its benign and self-limited character, treatment is required, both for itch relief and for cosmetic issues. The present study is a retrospective analysis of 13 patients (11 PLC and 2 PLEVA) treated in our institution with psoralen plus ultraviolet A (PUVA) or ultraviolet A combined with ultraviolet B (UVA/UVB) during the period 1998-2011. Read More

View Article
June 2013